Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

Download All
Join the experts to learn about early therapeutic interventions for NAFLD/NASH at this engaging live satellite symposium covering key recommendations from the latest clinical care guidelines and the safety and efficacy of emerging agents. Watch the on-demand webinar, download the slides, and read the companion faculty commentaries.
Rohit Loomba, MD, MHSc
Brent Tetri, MD

ClinicalThought

Read my take on NASH heterogeneity and its implications for treatment.

Brent Tetri, MD Released: September 29, 2022

Those who treat patients with type 2 diabetes may encounter nonalcoholic fatty liver disease. See an expert’s summary of guideline-recommended management and how we can better care for these patients.

Rohit Loomba, MD, MHSc Released: January 4, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings